Orientadores

PERFIL: Ana Paula Salles Moura Fernandes

Desenvolve projetos nas linhas de pesquisa de diagn�stico, tratamento e vacinas e epidemiologia molecular de doen�as infecciosas, em especial leishmanioses e de car�ter gen�tico. Umas das criadoras do Centro de Tecnologia em Vacinas da UFMG. Coordena projetos de cunho tecnol�gico, que culminaram com o desenvolvimento de produto e transfer�ncia de tecnologia da vacina Leish-Tec, contra a leishmaniose visceral canina e de testes de diagn�stico immunocromatogr�ficos.

Develops research projects in the areas of diagnosis, treatment, and vaccines, as well as molecular epidemiology of infectious diseases, particularly leishmaniasis. She is one of the founders of the UFMG Vaccine Technology Center. She coordinates technological projects, culminating in the product development and technology transfer of the Leish-Tec vaccine against canine visceral leishmaniasis and immunochromatographic diagnostic tests.

Publica��es mais relevantes

#	Descri��o	Op��o
1	A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D
2	Annexin A1 improves immune responses and control of tissue parasitism during Leishmania amazonensis infection in BALB/c mice
3	emporary Shutdown of ERK1/2 Phosphorylation Is Associated With Activation of Adaptive Immune Cell Responses and Disease Progression During Leishmania amazonensis Infection in BALB/c Mice.
4	Mapping Alterations Induced by Long-Term Axenic Cultivation of Leishmania amazonensis Promastigotes With a Multiplatform Metabolomic Fingerprint Approach.
5	ing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein.

Curr�culo Lattes:

E-mail: apfernandes.ufmg@gmail.com